• Daily Marijuana Observer Facebook
  • Daily Marijuana Observer Twitter
  • Daily Marijuana Observer StockTwits
  • Daily Marijuana Observer SA
  • Daily Marijuana Observer Instagram
  • Daily Marijuana Observer Youtube
  • Pinterest Social Icon
  • Daily Marijuana Observer Talk Market

Ireland Approves First Chronic Pain Cannabis License

November 21, 2017

 

As a medical marijuana bill finally makes its way through the Irish Dáil (lower House of Parliament) after a year of delays, the first medical license in Ireland to treat chronic pain with whole plant cannabis has been issued.

 

On Nov. 17, Ireland’s Department of Health granted a three-month license for THC to an unnamed patient. The recipient of the medicine suffers from severe chronic pain and medical professionals in Ireland are calling the prescription an “important development.”

 

It is the second time in Ireland’s history that someone has obtained permission for medical cannabis containing THC. The first license came in December of last year when 3-year-old Tristan Forde obtained access to treat a severe form of epilepsy. 

 

Medical cannabis in Ireland is currently illegal, however, a patient’s consultant can apply to the Minister of Health on a case-by-case basis in extreme circumstances.

 

“It is the first time that the Department of Health has recognized that THC can be used for the treatment of chronic pain,” said William McLoughlin, the national secretary of chronic pain Ireland (CPI).

 

Health Minister Simon Harris announced in February that cannabis products could be made available to some patients suffering from multiple sclerosis, epilepsy, and the side effects of chemotherapy.

 

Chronic pain was not included in the original plan, so CPI applied for the patient on their behalf. This move is significant because it has been reported that 20 percent of Ireland’s population suffers from chronic pain.

 

At the time CPI applied for the medicine, there were no formal application guidelines for chronic pain, so McLoughlin created one. The application included the method of delivery for the medicine, which was vaping or in tea, and the dosage the patient would be allowed.

 

“This is a very interesting and important development which demonstrates a recognition by Irish medical professionals and the minister for health, of the potential therapeutic value of medicinal cannabis for the treatment of chronic pain,” said David Finn, the co-director of the Centre for Pain Research at NUI Galway University. “Chronic pain is the most researched indication for cannabinoids, and the majority of clinical studies conclude that cannabis or cannabinoids can be effective in alleviating certain types of chronic pain.”

 

The medical marijuana bill in the Dáil is headed for its third stage of debate and will be presented to Ireland’s Health Committee early next year.

 

This article was originally published on Marijuana.com

 

About Jon Hiltz: Jonathan Hiltz has been a journalist, a TV producer and marijuana advocate for over sixteen years. He has a wife, two young children and lives in the Toronto area.

Please reload

LATEST NEWS
Please reload

Please reload

DMO

© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.